U.S. federal trademark · Serial No. 79408189
Biotechnology-derived products and preparations applied to the medical field, namely, in vivo cell and tissue reprograming pharmaceutical preparations for medical purposes for treating any conditions requiring cell and gene therapy; gene and cell therapy products and preparations, namely, cells targeting polymeric nanoparticle based on vector payloads for medical purposes; medical products, substances and preparations, namely, biotechnology-derived products and preparations being cell targeting pharmaceutical preparations comprising polymeric nanoparticles based on vector payloads and pharmaceutical products for immunotherapy and cancer treatment, autoimmune diseases, genetic diseases, diseases affecting the central nervous system; none of the aforementioned goods relating to or being in the nature of nutritional supplements
Medical research; pharmacological research being pharmaceutical research services; research and development in the field of biotechnology; biotechnology advice, namely, consulting services in the field of biotechnology and the development of pharmaceuticals for cell and gene therapy; preparation of reports in the field of biotechnology for scientific research purposes; information about scientific research in the field of biochemistry and biotechnology; scientific research in the fields of cell therapy and gene therapy; scientific research in the fields of in-vivo gene therapy and cell therapy; medical and scientific research in the field of immunotherapy; medical and scientific research in the field of oncology; medical and scientific research in the field of autoimmune disease; medical and scientific research in the field of genetic disease; medical and scientific research in the field of diseases affecting the central nervous system
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.